Trust Point’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$807K Sell
35,103
-7,658
-18% -$180K 0.06% 166
2026
Q2
$1.02M Sell
42,761
-1,033
-2% -$24.6K 0.09% 120
2026
Q1
$1.04M Buy
43,794
+3,525
+9% +$84.9K 0.09% 118
2025
Q4
$975K Buy
40,269
+959
+2% +$23.2K 0.08% 123
2025
Q3
$949K Sell
39,310
-3,228
-8% -$77.7K 0.08% 123
2025
Q2
$1.02M Sell
42,538
-110
-0.3% -$2.61K 0.1% 105
2025
Q1
$1.01M Buy
42,648
+290
+0.7% +$6.85K 0.09% 118
2024
Q4
$993K Buy
42,358
+2,057
+5% +$48.8K 0.07% 156
2024
Q3
$970K Sell
40,301
-11,878
-23% -$283K 0.07% 171
2024
Q2
$1.22M Sell
52,179
-1,608
-3% -$37.5K 0.1% 113
2024
Q1
$1.26M Sell
53,787
-1,311
-2% -$30.8K 0.1% 120
2023
Q4
$1.3M Buy
+55,098
New +$1.26M 0.11% 105

Other funds holding IBD

Trust Point's IBD Position: Q3 2026 in Review

Trust Point reduced its Inspire Corporate Bond ETF (IBD) stake by 18% in Q3 2026, selling an estimated $180K and leaving 35,103 shares worth $807K. The position accounts for 0.06% of the portfolio, ranked #166.

Trust Point first reported a position in IBD in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.3M in Q4 2023. 97 funds tracked by Wall St. Rank hold IBD as of Q3 2026.

  • Trust Point held 35,103 shares of Inspire Corporate Bond ETF worth $807K as of Q3 2026.
  • Trust Point sold 7,658 Inspire Corporate Bond ETF shares in Q3 2026, an estimated $180K.
  • Inspire Corporate Bond ETF made up 0.06% of Trust Point's portfolio in Q3 2026, its #166 holding.
  • Trust Point first reported a position in Inspire Corporate Bond ETF in Q4 2023 and has held it in 12 quarters since.
  • Trust Point's Inspire Corporate Bond ETF position peaked at $1.3M in Q4 2023.
  • 97 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q3 2026.

Based on Trust Point's 13F filing for Q3 2026, filed 27 Oct 2026.